Letter: Telaprevir triple therapy in chronic hepatitis C genotype 1 patients receiving haemodialysis

Aliment Pharmacol Ther. 2014 Jun;39(11):1342-4. doi: 10.1111/apt.12748.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antiviral Agents / administration & dosage*
  • Antiviral Agents / therapeutic use*
  • Female
  • Hepatitis C / drug therapy*
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Interferon-alpha / therapeutic use*
  • Male
  • Oligopeptides / administration & dosage
  • Oligopeptides / therapeutic use*
  • Polyethylene Glycols / therapeutic use*
  • Proline / administration & dosage
  • Proline / analogs & derivatives*
  • Protease Inhibitors / administration & dosage*
  • Ribavirin / therapeutic use*

Substances

  • Antiviral Agents
  • Interferon-alpha
  • Oligopeptides
  • Protease Inhibitors
  • Polyethylene Glycols
  • Ribavirin
  • telaprevir
  • N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide
  • Proline